Full Breakdown
Surge in Drug-Resistant "Nightmare Bacteria" Infections in the U.S.
9/26/2025, 3:01:57 AM
Alarming Increase in NDM-CRE Infections
Recent data from the Centers for Disease Control and Prevention (CDC) reveals a significant rise in infections caused by drug-resistant bacteria known as NDM-producing carbapenem-resistant Enterobacterales (NDM-CRE). Between 2019 and 2023, cases of NDM-CRE surged by over 460%, with 1,831 of the 4,341 reported carbapenem-resistant infections in 2023 attributed to this strain. The overall rate of carbapenem-resistant infections rose from just under 2 per 100,000 people in 2019 to more than 3 per 100,000 in 2023, marking a 69% increase.
Background on NDM-CRE
The NDM gene, or New Delhi metallo-beta-lactamase, enables bacteria to resist a wide range of antibiotics, including carbapenems, which are often considered last-resort treatments for severe infections. Initially linked to patients receiving medical care overseas, NDM-CRE infections were once rare in the U.S. However, their prevalence has increased dramatically, raising concerns among health experts about the potential for community spread and the difficulty in treating common infections, such as urinary tract infections.
Contributing Factors to the Rise
Experts attribute the rise in NDM-CRE infections to several factors, including the misuse of antibiotics, particularly during the COVID-19 pandemic. Dr. Jason Burnham from Washington University noted that the surge in antibiotic prescriptions during the pandemic likely contributed to increased drug resistance. Misuse can occur through unfinished or unnecessary prescriptions, which fail to eliminate bacteria and instead strengthen them.
Official Responses and Recommendations
The CDC has emphasized the need for improved surveillance and testing capabilities to combat the spread of NDM-CRE. Danielle Rankin, an epidemiologist at the CDC, stated that healthcare providers must have access to proper testing to select effective treatments. Additionally, experts recommend that patients advocate for thorough testing when experiencing persistent infections.
Criticism and Concerns
Despite the alarming statistics, the CDC's report may underestimate the true scope of the issue, as many states, including California, Florida, New York, and Texas, do not fully report or test for these infections. Dr. Burnham highlighted that the lack of comprehensive data could mask the actual number of cases, complicating public health responses.
Verbatim Quotes
- “The rise of NDMs in the U.S. is a grave danger and very worrisome.” — David Weiss, Infectious Diseases Researcher, Emory University
- “We know that there was a huge surge in antibiotic use during the pandemic, so this likely is reflected in increasing drug resistance.” — Dr. Jason Burnham, Washington University
Conclusion
The rise of NDM-CRE infections poses a significant public health challenge in the U.S., with implications for treatment and infection control. As the healthcare community grapples with this growing threat, enhanced surveillance, better testing, and responsible antibiotic use will be crucial in mitigating the impact of these "nightmare bacteria."
